Notably, ELF3, which plays a critical role in epithelial cell differentiation and tumorigenesis, exhibits a mutation frequency of 12.65% in BLCA, significantly higher than in other cancers (Figure 1B). Here, ELF3 is linked to bladder transitional cell carcinoma.